Obesity clinical trials in Nebraska
9 studies for Obesity are looking for participants at sites in Nebraska.
Cities in Nebraska
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- Velocity Clinical Research - Omaha, Omaha
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT07685808A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- University Of Nebraska Medical Center, Omaha
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07595549Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
- Children's Hospital & Medical Center, Omaha
RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated Nov 4, 2026 · NCT07817875A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Omaha Childrens Hospital, Omaha
- Velocity Clinical Research, Omaha
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Nov 4, 2026 · NCT06672549Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Bryan Heart, Lincoln
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Oct 29, 2026 · NCT07037459A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Omaha
- Research Site, Omaha
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07784270A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Omaha
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 79 · All sexes · Updated Oct 20, 2026 · NCT07654374A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Bryan Heart, Lincoln
- Velocity Clinical Research Lincoln, Lincoln
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07567001Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Omaha
RecruitingPhase 3
Ages 18 to 79 · All sexes · Updated Aug 10, 2026 · NCT07654361From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.